CXCL1/CXCR2 signaling are widely studied in cardiovascular diseases, including cardiac hypertrophy (60), hypertension (61), aneurysm (62), and atherosclerosis (63). This evidence concerns the gene CXCL1 and cardiac hypertrophy.